LGF
XBIO icon

LGT Group Foundation’s Xenetic Biosciences XBIO Stock Holding History

LGT Group Foundation’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,000
Closed -$41.1K – 300
2025
Q2 		$41.1K Hold
11,000
– – ﹤0.01% 290
2025
Q1 		$41.1K Hold
11,000
– – ﹤0.01% 287
2024
Q4 		$41.1K Buy
+11,000
New +$44.4K ﹤0.01% 270

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIP
Alexis Investment Partners Montgomery, Texas $171M AUM 32.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWM
Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

LGT Group Foundation's XBIO Position: Q3 2025 in Review

LGT Group Foundation sold out of Xenetic Biosciences (XBIO) in Q3 2025, closing a stake of 11,000 shares — an estimated $41.1K sold.

LGT Group Foundation first reported a position in XBIO in Q4 2024 and held it in 3 quarters. The position peaked at $41.1K in Q2 2025. 10 funds tracked by Wall St. Rank hold XBIO as of Q3 2025.

  • LGT Group Foundation reported no remaining Xenetic Biosciences position as of Q3 2025 after selling out during the quarter.
  • LGT Group Foundation sold 11,000 Xenetic Biosciences shares in Q3 2025, an estimated $41.1K.
  • LGT Group Foundation first reported a position in Xenetic Biosciences in Q4 2024 and held it in 3 quarters.
  • LGT Group Foundation's Xenetic Biosciences position peaked at $41.1K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2025.

Based on LGT Group Foundation's 13F filing for Q3 2025, filed 13 Nov 2025.